Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-10-15
著者
-
Yamazaki Rie
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Yamazaki Rie
Division Of Hematology Saitama Medical Center Jichi Medical University
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
KANDA Yoshinobu
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
Kagami Yoshitoyo
東京大学医科学研究所ヒトゲノム解析センター
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
OKUDA Shinya
Division of Hematology and Oncology, Department of Internal Medicine, Toho University School of Medi
-
Nakasone Hideki
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Okuda Shinya
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Okuda Shinya
Division Of Hematology And Oncology Department Of Internal Medicine Toho University School Of Medici
-
Kanda Yoshinobu
Department Of Hematology Tokyo Women's Medical University
-
Sato Miki
Division Of Hematology Saitama Medical Center Jichi Medical University
-
KAKO Shinichi
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
TERASAKO Kiriko
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
KIMURA Shun-ichi
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
OSHIMA Kumi
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
NISHIDA Junji
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
Ishida Yoko
Division Of Biochemistry Niigata University Graduate School Of Medical And Dental Sciences
-
Oshima Kumi
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Nishida Junji
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kako Shinichi
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kanda Yoshinobu
Division Of Hematology And Oncology Okayama University Hospital
-
Terasako Kiriko
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Sato Ken
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kashiwagi Yoichiro
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Kikuchi Misato
Division Of Hematology Saitama Medical Center Jichi Medical University
-
SAKAMOTO Kana
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
ASHIZAWA Masahiro
Division of Hematology, Saitama Medical Center, Jichi Medical University
-
Ashizawa Masahiro
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Ishida Yoko
Division Of Hematology Saitama Medical Center Jichi Medical University
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- The Authors Reply: Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies
- Insomnia and Depression during Protective Isolation in Patients with Hematological Disorders
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
- Early Diagnosis of Central Nervous System Aspergillosis with Combination Use of Cerebral Diffusion-weighted Echo-planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
- Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
- Periostin and bone marrow fibrosis
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- ONTOGENY OF cLim2 GENE EXPRESSION IN PORCINE PITUITARY AND ROLE IN LHβ GENE EXPRESSION(Endocrinology)(Proceedings of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- TRANSCRIPTIONAL CONTROL BY GNRH FOR THE PORCINE GTHα-SUBUNIT GENE IN LβT2 CELL(Endocrinology)(Proceedings of the Seventy-Third Annual Meeting of the Zoological Society of Japan)
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Low concentration of serum haptoglobin has impact on understanding complex pathophysiology in patients with acquired bone marrow failure syndromes
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- A case of intravascular large B-cell lymphoma of the cutaneous variant : the first case in Asia
- Kidney-limited intravascular large B cell lymphoma : a distinct variant of IVLBCL?
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Ischemic Colitis as a Manifestation of Thrombotic Microangiopathy Following Bone Marrow Transplantation
- Rapid progression of chronic myelomonocytic leukemia following diaminodiphenyl sulphone treatment for dermatitis herpetiformis
- Subcellular localization of the MEN, MLI/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23;p13.1) translocation
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Systemic Infection due to Acremonium after Allogeneic Peripheral Blood Stem Cell Transplantation
- Acinetobacter lwoffii Septicemia Associated with a Peripheral Intravascular Catheter
- Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Late-onset pneumatosis cystoides intestinalis associated with non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
- Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma : a case report and literature review
- Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation
- A case of adult Langerhans cell histiocytosis showing successfully regenerated osseous tissue of the skull after chemotherapy
- Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells
- Non-Tuberculous Mycobacterial Infection Localized in Small Intestine Developing after Allogeneic Bone Marrow Transplantation
- Gelatinous Degeneration in a Recipient of Allogeneic Bone Marrow Transplantation
- Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation
- Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- Splenic Peliosis in a Patient with Aplastic Anemia during Danazol Therapy
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma
- Clinical impact of radiotherapy for locally advanced pancreatic cancer
- Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis
- Hepatocellular apoptosis associated with cytotoxic T/natural killer-cell infiltration in chronic active EBV infection
- Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype : Their possible involvement in pathological processes
- Is ^F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation
- ENDOSCOPIC ULTRASOUND-GUIDED CHOLEDOCHODUODENOSTOMY
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration
- Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments
- Infant juvenile myelomonocytic leukemia (JMML) with rapid infiltration of multiple organs
- Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL)
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Guest editorial : role of monoclonal antibodies for the prevention and treatment of graft-versus-host disease
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Fulminant Hepatic Failure Caused by Adenovirus Infection Mimicking Peliosis Hepatitis on Abdominal Computed Tomography Images after Allogeneic Hematopoietic Stem Cell Transplantation
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study